Several other biomarkers for prostate cancer are known [3], including PCA3, a long non-coded RNA transcript expressed in the urine of prostate cancer patients, which appears to be an ideal biomarker of PCa [4]. This evidence concerns the gene PCA3 and posterior cortical atrophy.